Welcome to Asuragen
Asuragen is a fully integrated RNA-based therapeutic and diagnostics company with a core focus on miRNA. Asuragen is leveraging its broad miRNA/mRNA IP portfolio to build a significant business focused on three product segments:
While managed as three distinct business units, Asuragen utilizes its expertise and understanding of miRNA/mRNA in each category. Asuragen is uniquely positioned to take advantage of the recent discoveries of the role that miRNAs play in disease.
Learn more about Molecular Diagnostics
Learn more about microRNA-based Therapeutics
Learn more about Pharmacogenomics
Contact Us
History
On March 1, 2006, Ambion completed the sale of its Research Products division to Applied Biosystems Group (NYSE: ABI), an Applera Corporation business, resulting in the simultaneous spin-off and creation of Asuragen, Inc.
Learn more about Asuragen's history
Asuragen Culture
Asuragen is proud of its culture, which focuses on providing an exciting and challenging work environment where individuals are part of a team and are recognized for their creativity and ability to meet company goals. Asuragen combines cutting edge science and technology development and the entrepreneurial spirit of a new startup with the foundation of a far more established company in its infrastructure and experienced workforce brought from Ambion.
Learn more about Asuragen's Culture